Evan M Hersh

  • 19346 Citations
  • 67 h-Index
1965 …2018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Evan M Hersh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Davis, T. P., Hersh, E. M., Weinstein, R. S., Miesfeld, R., Miller, T. P., Tsaprailis, G., Lynch, R., Chow, H., Nagle, R. B., Watts, G. S., Thomson, C., Roe, D., Stratton, S. P., Alberts, D. S., Hurley, L., Baker, A. F., Livingston, R. B., Dorr, R. T., Cress, A. E., Briehl, M. M., Mash, E. A., Duffy, J., Jones, S., Leibovitz, A., Meyskens, F., Moon, T., Trent, J., Newkirk, D., Von Hoff, D., Mount, D., Doetschman, T., Liebler, D., Marshall, J., McGovern, K., Grogan, T., Kraft, A., Powis, G., Peng, Y., Gerner, E., Aickin, M., Ritenbaugh, C., Taylor, C., Powell, M. B., Bowden, T., Taetle, R., Salmon, S., Ignatenko, N., Bhattacharyya, A. K., Futscher, B. W., Barton, J. K., Montfort, W. "., Roe, D., Garland, L. L., Doetschman, T. C., Kraft, A., Chow, H., Ellis, N. & Zeng, Y. -.

National Institutes of Health


Project: Research project


    Hersh, E. M. & Taetle, R.

    National Institutes of Health


    Project: Research project


    Hersh, E. M., Shannon, W., Stephens, E. B. & Chirigos, M.

    National Institutes of Health


    Project: Research project

  • Research Output

    A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

    Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E., Jan 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

    MMAIT-IV Clinical Trial Group, Dec 1 2017, In : Annals of Surgical Oncology. 24, 13, p. 3991-4000 10 p.

    Research output: Contribution to journalArticle

  • 31 Scopus citations

    A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

    Hersh, E. M., Del Vecchio, M., Brown, M. P., Kefford, R., Loquai, C., Testori, A., Bhatia, S., Gutzmer, R., Conry, R., Haydon, A., Robert, C., Ernst, S., Homsi, J., Grob, J. J., Kendra, K., Agarwala, S. S., Li, M., Clawson, A., Brachmann, C., Karnoub, M. & 3 others, Elias, I., Renschler, M. F. & Hauschild, A., Nov 2015, In : Annals of Oncology. 26, 11, p. 2267-2274 8 p., mdv324.

    Research output: Contribution to journalArticle

  • 30 Scopus citations

    Ipilimumab pharmacotherapy in patients with metastatic melanoma

    Jeter, J. M., Cranmer, L. D. & Hersh, E. M., Jan 1 2012, In : Clinical Medicine Insights: Oncology. 6, p. 275-286 12 p.

    Research output: Contribution to journalReview article

  • 8 Scopus citations

    A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

    Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 1 2011, In : Investigational New Drugs. 29, 3, p. 489-498 10 p.

    Research output: Contribution to journalArticle

  • 218 Scopus citations